Product Information
AMLODIPINE BESYLATE 5 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0102 per EA under NDC 59762201003. Its NADAC has been published 361 times since Nov 6, 2019.
FDA first approved this application on Jul 31, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762201003
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019787FDA Approved
7/31/1992
TE Code
AB
On Market Since
6/24/2019
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE BESYLATE 5 MG TAB has been published 361 times since Nov 6, 2019, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0102 per EA |
|---|---|
| All-time high | $0.0143 (Mar 13, 2024) |
| All-time low | $0.0095 (Nov 20, 2024) |
| 52-week high | $0.0113 |
| 52-week low | $0.0101 |
| Median price | $0.0113 |
| Average price | $0.0114 |
| Largest weekly change | +19.6% (Jan 17, 2024) |
| Weeks tracked | 361 |
| Tracking since | Nov 6, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE BESYLATE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 5 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0102 per EA (NDC 59762201003), effective Sep 30, 2026.
How has the price of AMLODIPINE BESYLATE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 5 MG TAB has declined 26.2%. It has been tracked across 361 weekly CMS publications since Nov 6, 2019.
What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 5 MG TAB?
Since Nov 6, 2019, the NADAC for AMLODIPINE BESYLATE 5 MG TAB has ranged from a low of $0.0095 (Nov 20, 2024) to a high of $0.0143 (Mar 13, 2024), with a median of $0.0113 per EA.
Are there cheaper alternatives to AMLODIPINE BESYLATE 5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE BESYLATE 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE BESYLATE 5 MG TAB?
AMLODIPINE BESYLATE 5 MG TAB (NDC 59762201003) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.